Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.450
-0.040 (-2.68%)
Feb 4, 2026, 12:50 PM EST - Market open
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $54.44 million as of February 4, 2026. Its market cap has decreased by -44.26% in one year.
Market Cap
54.44M
Enterprise Value
-87.07M
1-Year Change
-44.26%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $54.44M, a decrease of -90.33%. That is a compound annual growth rate of -69.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 55.94M | -8.02% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 60.99M |
| Tevogen Bio Holdings | 59.79M |
| Grace Therapeutics | 58.18M |
| TScan Therapeutics | 57.88M |
| Acrivon Therapeutics | 57.11M |
| Nutriband | 56.53M |
| PMV Pharmaceuticals | 56.40M |
| ImmuCell | 55.36M |